News
- Nobilis Therapeutics Announces FDA Clearance of IND to Commence Phase 2b Trial of NBTX-001 Inhaler for Treatment of Panic Disorder July 22, 2020
- Nobilis Therapeutics Announces IND Filing for a Phase 2b Clinical Trial of NBTX-001 Drug/Device Combination for Treatment of Panic Disorder June 23, 2020
- Nobilis Therapeutics Has Won NIH’s National Institutes of Drug Abuse “$100,000 For Start a SUD Startup 2020” Spring Challenge June 22, 2020
- Nobilis Therapeutics Receives a Notice of Allowance for its European Patent Application “Therapeutic Immune Modulation Using Noble Gas Compositions” May 2, 2020
- Imminent Mental Health Crisis in America April 10, 2020
Recent Posts
- Nobilis Therapeutics Announces FDA Clearance of IND to Commence Phase 2b Trial of NBTX-001 Inhaler for Treatment of Panic Disorder
- Nobilis Therapeutics Announces IND Filing for a Phase 2b Clinical Trial of NBTX-001 Drug/Device Combination for Treatment of Panic Disorder
- Nobilis Therapeutics Has Won NIH’s National Institutes of Drug Abuse “$100,000 For Start a SUD Startup 2020” Spring Challenge
- Nobilis Therapeutics Receives a Notice of Allowance for its European Patent Application “Therapeutic Immune Modulation Using Noble Gas Compositions”
- Imminent Mental Health Crisis in America
Recent Comments